Sanjiv S. Modi

Hematology Oncology | Hematology | Oncology

1600 W. Route 6
Morris, IL 60450

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.

An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.

Journal: Cancer

Published: August 27, 2013

Showing 1-1 of 1

Last Updated: 09/26/2026